Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- 5-(aminomethyl)-3(2H)-isoxazolone
- Correlated keywords
- ?-aminobutyric acid GABA neurotransmitters GABAA GABAC GABAB agonists benzodiazepines memory neurochemistry neuroscience GABA-A Receptor alpha Subunit GABA Benzodiazepine Receptors GABA A Receptor gamma Subunit GABA A Receptor delta Subunit GABA A Receptor alpha Subunit GABA Benzodiazepine Receptor GABA A Receptor beta Subunit Benzodiazepine-GABA Receptor Benzodiazepine GABA Receptor GABA-A Receptor rho Subunit GABA A Receptor rho Subunit Benzodiazepine Receptors Benzodiazepine Receptor Receptors Muscimol Receptors, Diazepam Muscimol Receptor Diazepam Receptor GABA A Receptors GABA-A Receptor GABA A Receptor
- Product Overview:
The amino acid ?-aminobutyric acid (GABA) is an inhibitory neurotransmitter that acts through two families of heteromeric ligand-gated ion channels, GABAA and GABAC and a G protein-coupled receptor, GABAB. Muscimol is a full GABAA agonist and partial GABAC agonist. It binds GABAA on both high- and low-affinity sites (Kd = 10 and 270 nM, respectively), stimulating chloride efflux with an EC50 value of 200 nM.{18163} Benzodiazepines enhance the effects of muscimol via GABAA without altering its binding.{18163,18162} Muscimol activates GABAC receptors with an EC50 value of 1.3 ?M.{18156} It also acts as an inhibitor of GABAA uptake and a substrate for the GABA-metabolizing enzyme GABA transaminase.{17741} Muscimol impairs memory formation and retrieval in mice and attenuates airway constriction in guinea pigs in vivo.{18159,18160}
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.